Iguana Healthcare Management’s Spectranetics Corp SPNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-110,000
Closed -$4.22M 85
2017
Q2
$4.22M Buy
110,000
+35,000
+47% +$1.01M 2.39% 15
2017
Q1
$2.18M Sell
75,000
-35,000
-32% -$933K 1.08% 31
2016
Q4
$2.69M Sell
110,000
-110,000
-50% -$2.59M 1.61% 24
2016
Q3
$5.52M Buy
220,000
+110,000
+100% +$2.57M 0.98% 36
2016
Q2
$2.06M Hold
110,000
0.84% 37
2016
Q1
$1.6M Buy
110,000
+60,000
+120% +$831K 0.59% 46
2015
Q4
$753K Buy
+50,000
New +$660K 0.25% 60
2015
Q2
Sell
-50,000
Closed -$1.74M 95
2015
Q1
$1.74M Hold
50,000
0.73% 43
2014
Q4
$1.73M Sell
50,000
-65,000
-57% -$2.03M 0.84% 42
2014
Q3
$3.06M Sell
115,000
-10,000
-8% -$269K 1.63% 21
2014
Q2
$2.86M Buy
+125,000
New +$2.9M 1.33% 32

Iguana Healthcare Management's SPNC Position: Q3 2017 in Review

Iguana Healthcare Management sold out of Spectranetics Corp (SPNC) in Q3 2017, closing a stake of 110,000 shares — an estimated $4.22M sold.

Iguana Healthcare Management first reported a position in SPNC in Q2 2014 and held it in 11 quarters. The position peaked at $5.52M in Q3 2016. 0 funds tracked by Wall St. Rank hold SPNC as of Q3 2017.

  • Iguana Healthcare Management reported no remaining Spectranetics Corp position as of Q3 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 110,000 Spectranetics Corp shares in Q3 2017, an estimated $4.22M.
  • Iguana Healthcare Management first reported a position in Spectranetics Corp in Q2 2014 and held it in 11 quarters.
  • Iguana Healthcare Management's Spectranetics Corp position peaked at $5.52M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Spectranetics Corp as of Q3 2017.

Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.